Virginia Tech™home

Archived Seminar: Molecular Programs Defining Tumor-Specific T cell Dysfunction and Therapeutic Reprogrammability

Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC

Archived Seminar: Molecular Programs Defining Tumor-Specific T cell Dysfunction and Therapeutic Reprogrammability

Date: Sept. 27, 2019
Time: 11:00 a.m. - 12:00 p.m.

 

You May Also Be Interested In...

Andrea Schietinger, Ph.D.

Andrea Schietinger, Ph.D.

Assistant Member
Immunology Program
Sloan Kettering Cancer Institute